Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
06.05.24
Read more
We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an approach that starts and ends with patients, we’re expanding the reach of genetically targeted therapies.